-- title: "Avian Influenza H5N1 in Dairy Cattle: Emerging Threat and Molecular Surveillance" category: "livestock-viruses" metaDescription: "A comprehensive review of H5N1 avian influenza in dairy cattle covering spillover events, clinical signs, milk PCR diagnostics, and genomic surveillance strategies for early detection." primaryKeyword: "H5N1 in dairy cattle" secondaryKeywords: ["avian influenza H5N1 cattle", "bovine H5N1 molecular diagnostics", "milk PCR testing H5N1", "genomic surveillance H5N1 dairy", "highly pathogenic avian influenza dairy"]
Avian Influenza H5N1 in Dairy Cattle: Emerging Threat and Molecular Surveillance
Introduction
The incursion of highly pathogenic avian influenza (HPAI) H5N1 virus clade 2.3.4.4b into dairy cattle populations represents a paradigm shift in the host range of influenza A viruses. Historically considered a pathogen restricted to avian species and occasional spillover into mammals, H5N1 has demonstrated an unprecedented capacity to establish productive infection in Bos taurus dairy herds. This review synthesizes current knowledge on spillover events, clinical presentation, molecular diagnostics using milk matrices, and genomic surveillance frameworks essential for early detection and outbreak control.
Spillover Events and Host Adaptation
The transmission of HPAI H5N1 from wild birds to dairy cattle was first identified through epidemiological investigations linking outbreaks to contiguous feedlots and shared water sources. Experimental inoculation studies demonstrated that dairy cows could be infected with a low infectious dose, although onward transmission within herds exhibited significant barriers [4]. The factors governing this spillover include viral receptor distribution, environmental persistence, and husbandry practices.
Sialic acid receptor specificity is a critical determinant of host tropism. Avian influenza viruses preferentially bind alpha-2,3-linked sialic acids, which are abundant in the avian respiratory and intestinal tracts. Mammalian adapted viruses typically acquire affinity for alpha-2,6-linked sialic acids. Mammary gland epithelial cells in cattle express both receptor types, with alpha-2,3 predominance in the alveoli and alpha-2,6 in ductal epithelium. This dual receptor expression may facilitate H5N1 entry and replication in the udder, leading to high viral loads in milk.
Molecular adaptation of the hemagglutinin (HA) and polymerase basic 2 (PB2) genes has been documented in bovine isolates. Mutations such as PB2 E627K and HA Q226L (H3 numbering) enhance replication efficiency in mammalian cells [7]. The selective pressure in the bovine mammary microenvironment may accelerate these adaptive changes, increasing the risk of further mammalian adaptation. The EFSA overview confirmed the continued circulation of clade 2.3.4.4b across multiple continents with repeated incursions into dairy operations [13].
Clinical Signs in Dairy Cattle
Infected dairy cows exhibit a distinct clinical syndrome that differs from classical avian influenza in poultry. The disease is characterized by an acute onset of anorexia, decreased rumination, and a marked drop in milk production. Affected animals often present with thickened, colostrum-like milk that may be yellow or bloody. Systemic signs include pyrexia (rectal temperatures exceeding 39.5 degrees Celsius), respiratory distress with serous nasal discharge, and diarrhea.
The mammary gland is a major target organ. Histopathological examination reveals necrotizing mastitis with extensive infiltration of neutrophils and macrophages. Immunohistochemistry demonstrates viral antigen in mammary epithelial cells and luminal secretions. Systemic infection is supported by the detection of viral RNA in blood and multiple tissues, but the mammary gland appears to be the primary site of viral replication and shedding.
The duration of clinical signs varies. Acute signs persist for 3 to 7 days, but viral RNA can be detected in milk for several weeks after clinical resolution. Antibody responses develop by 10 to 14 days post-infection and may persist for over a year [2]. This prolonged seropositivity complicates interpretation of serosurveys but provides a window for retrospective surveillance.
Milk as a Diagnostic Specimen
Milk is the optimal diagnostic specimen for H5N1 detection in dairy cattle due to its high viral load, non-invasive collection, and relevance to food safety. Viral RNA concentrations in milk from infected cows can exceed 10^7 genome copies per milliliter, several orders of magnitude higher than nasal swab titers. This abundance allows robust detection by reverse transcription quantitative PCR (RT-qPCR).
The stability of influenza viruses in milk is a critical factor for diagnostic accuracy and risk assessment. H5N1 virus remains infectious in unpasteurized milk for extended periods under refrigeration, and viral RNA can be detected for weeks [9]. Pasteurization effectively inactivates the virus, but raw milk consumption poses a zoonotic hazard. Therefore, molecular testing of bulk tank milk has become a frontline surveillance tool.
A longitudinal study of California dairy farms demonstrated that bulk tank milk RT-qPCR positivity correlates with pen-level prevalence [10]. Testing of individual cow milk samples enhances sensitivity for early detection. Sample handling protocols require careful attention to prevent RNA degradation; milk should be refrigerated immediately and processed within 48 hours. Addition of guanidinium-based lysis buffers stabilizes RNA for transport.
Molecular Detection Methods
RT-qPCR targeting the matrix (M) gene is the standard screening assay for influenza A. Subtyping assays specifically detect H5 hemagglutinin and N1 neuraminidase sequences. An interlaboratory comparison study revealed method-dependent sensitivity variability, with some PCR assays failing to detect low-titer positive milk samples [8]. This variability underscores the need for validated, standardized protocols across diagnostic laboratories.
High-throughput RT-qPCR systems adapted for influenza subtyping allow rapid screening of large numbers of samples. A panel that simultaneously detects H1pdm09, H3, and H5 was successfully validated for high-throughput platforms, enabling differentiation of seasonal and avian strains in bovine specimens [15]. The throughput capacity is essential for outbreak response where hundreds of samples must be processed daily.
The following table summarizes the key molecular targets and their diagnostic utility:
| Target Gene | Assay Purpose | Analytical Sensitivity | Specimen Type |
|---|---|---|---|
| Matrix (M) | Influenza A screening | 10-100 copies/reaction | Milk, nasal swab, tissue |
| Hemagglutinin (H5) | H5 subtype confirmation | 50-200 copies/reaction | Milk, nasal swab |
| Neuraminidase (N1) | N1 subtype confirmation | 50-200 copies/reaction | Milk, nasal swab |
| PB2 | Adaptation marker | Sequencing required | High-titer samples |
Genomic Surveillance Strategies
Next-generation sequencing (NGS) of H5N1 genomes from dairy cattle provides essential data for tracking viral evolution, transmission networks, and emergence of mammalian adaptive mutations. The 2024-2025 emergency response in the United States employed a coordinated sequencing strategy targeting full-genome recovery from clinical specimens, including milk [11]. Amplicon-based approaches using multiplex primer panels covering all eight gene segments yield complete genomes within 24 to 48 hours of sample receipt.
Bioinformatic analysis pipelines must account for the high viral load in milk, which facilitates deep sequencing but also presents challenges related to mixed infections and sample cross-contamination. Consensus genome assembly followed by phylogenetic placement using maximum likelihood or Bayesian methods allows identification of introduction events and assessment of within-herd diversity.
The Global Initiative on Sharing All Influenza Data (GISAID) serves as the primary repository for H5N1 sequences. Real-time sharing of genomic data enables rapid risk assessment by international veterinary and public health agencies. Integration of genomic data with epidemiological metadata (herd location, movement records, environmental sampling) supports source attribution.
Computational modeling of within-herd transmission dynamics using approximate Bayesian computation approaches can estimate transmission rates from serial prevalence data [5]. These models incorporate testing frequency, diagnostic sensitivity, and herd size to generate parameter estimates for R0 (basic reproduction number) and the duration of infectiousness. Such models inform culling and movement restriction policies.
Computational and Systems Approaches
High-resolution digital twins of interacting livestock, wild bird, and human ecosystems have been developed to simulate multihost epidemic spread [3]. These agent-based models incorporate livestock movement networks, wild bird migration patterns, and environmental transmission pathways. They allow scenario testing for intervention strategies such as enhanced biosecurity, vaccination, or depopulation.
Machine learning algorithms for predicting veterinary viral outbreaks can integrate climate data, wild bird surveillance counts, and livestock density maps to generate risk scores at farm or regional levels. These tools are discussed in the related article Machine Learning Algorithms for Predicting Veterinary Viral Outbreaks.
Systems biology approaches have been applied to bovine mammary H5N1 infection. Compartmentalized cytokine networks and systemic immune remodeling were characterized in infected udder tissue [1]. Elevated levels of pro-inflammatory cytokines (IL-6, TNF-alpha, IFN-gamma) in milk and serum correlate with disease severity and viral load. These immune signatures may serve as biomarkers for early detection.
Immune Responses and Vaccination
Infection with H5N1 elicits robust antibody responses in cattle, detectable by hemagglutination inhibition (HI) and enzyme-linked immunosorbent assay (ELISA). Antibodies persist for more than a year, indicating long-lived humoral immunity [2]. However, the relationship between antibody titers and protection against reinfection is not fully defined.
Vaccination strategies are under investigation for dairy cattle. Dual-route vaccination using a modified vectored vaccine induced systemic and mucosal immunity in both murine and bovine models [14]. Mucosal IgA responses in the mammary gland may be particularly important for reducing milk shedding. Effective vaccines could reduce viral transmission but require regulatory approval and careful monitoring to avoid interference with serological surveillance.
The related article Highly Pathogenic Avian Influenza (HPAI) H5N1 in Poultry: Clinical Signs and Molecular Surveillance provides comparative context for bovine infection.
Control Strategies
Control of H5N1 in dairy herds relies on rapid detection, isolation of affected animals, and enhanced biosecurity. Movement restrictions on infected premises prevent spread to naive herds. Depopulation of affected herds has been employed in some jurisdictions, but the economic impact on the dairy industry is substantial.
Environmental decontamination is challenging due to the virus's stability in organic material. Influenza A virus is inactivated by heat (70 degrees Celsius for 30 minutes), ultraviolet radiation, and lipid solvents. Sodium hypochlorite and quaternary ammonium compounds are effective disinfectants when used at appropriate concentrations.
The decision tree below outlines a molecular surveillance workflow for H5N1 in dairy herds:
flowchart TD
A[Clinical suspicion: drop in milk production, thickened milk, pyrexia], > B[Collect individual milk samples from affected cows]
B, > C[Pool into pen-level or bulk tank sample]
C, > D[Transport to laboratory at 4 degrees Celsius]
D, > E{RNA extraction and RT-qPCR for influenza A M gene}
E, >|Negative| F[Repeat testing if clinical signs persist]
E, >|Positive| G[Subtype by H5-specific RT-qPCR]
G, > H[Confirm N1 subtype]
H, > I[Sequencing of HA, NA, and PB2 genes]
I, > J[Phylogenetic analysis and mutation screening]
J, > K[Report to veterinary authorities]
K, > L[Implement movement restrictions and biosecurity]
L, > M[Serial testing of bulk tank milk until negative]
Zoonotic Potential and One Health Context
While this review focuses on veterinary aspects, the zoonotic potential of H5N1 in dairy cattle warrants mention. Mammalian adaptation mutations increase the theoretical risk of human infection. The molecular basis of pathogenicity and zoonotic potential was described in detail [12]. Ferret transmission studies demonstrated variable efficiency of mammalian origin H5N1 strains, with some strains transmitting via direct contact but not via aerosols [6]. This suggests that sustained human-to-human transmission is not yet a characteristic of bovine-derived viruses.
Diagnostic Challenges
Several diagnostic challenges persist. First, sample collection timing is critical. Viral RNA in milk declines after the acute phase, but PCR can remain positive for weeks. Second, inhibitors in milk (fat, proteins, calcium) can reduce PCR efficiency. Use of internal controls and optimized extraction protocols is necessary. Third, interlaboratory variability in sensitivity requires ongoing proficiency testing [8].
CRISPR-based diagnostics are emerging as potential field-deployable tools. These are reviewed in the companion article CRISPR-Based Diagnostics for Avian Influenza: Mechanisms, Platforms, and Veterinary Applications.
Conclusion
HPAI H5N1 has established itself as an emergent pathogen in dairy cattle, with the mammary gland serving as a primary replication site. Milk-based molecular diagnostics, particularly RT-qPCR, provide the most sensitive and practical surveillance tool. Genomic surveillance is essential for tracking viral evolution and informing control measures. Continued investment in diagnostic validation, computational modeling, and vaccine development is necessary to mitigate the threat to dairy production and animal health.
References
Singh G, Cool K, Ghimire S, et al. Compartmentalized cytokine networks and systemic immune remodelling in bovine mammary H5N1 infection. Emerg Microbes Infect. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42249592/
Shittu I, Rodriguez J, Oguzie JU, et al. Detection of antibodies to avian influenza virus H5N1 clade 2.3.4.4b in naturally infected cattle for more than a year. Sci Rep. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42209625/
Adiga A, Chopra A, Wilson ML, et al. A high-resolution, US-scale digital similar of interacting livestock, wild birds, and human ecosystems for multihost epidemic spread. Proc Natl Acad Sci U S A. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42207910/
Lee C, Tarbuck NN, Cochran HJ, et al. Dairy cows infected with influenza A(H5N1) reveals low infectious dose and transmission barriers. Nat Commun. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42177170/
Malladi S, Carestia A, Seys SA, et al. Estimating the within-herd transmission rate of highly pathogenic avian influenza H5N1 virus in a dairy herd using an approximate Bayesian computation approach. J Dairy Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42155711/
Quirk GE, Vu MN, Le Sage V, et al. Variable transmission efficiency of mammalian origin HPAI D1.1 H5N1 strains in ferrets. bioRxiv. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42146553/
Ding K, Ding Y. H5N1 avian influenza in dairy cattle: Molecular adaptation, transmission mechanisms, and control strategies. Virology. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42107281/
Miller MR, Frost K, Smith EL, et al. Evaluation of PCR-based H5N1 influenza detection methods in milk from an interlaboratory comparison study demonstrating method-dependent sensitivity variability. J Food Prot. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42103287/
Schafers J, Warren CJ, Yang J, et al. Stability of influenza viruses in the milk of cows and sheep. J Gen Virol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42095438/
Stenkamp-Strahm C, Melody B, Brinson P, et al. A longitudinal study of influenza A viral detection in bulk tank and pen-level milk collected from dairy farms in California affected by highly pathogenic avian influenza H5N1. J Dairy Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42092544/
Frederick JC, Lacek KA, Wersebe MJ, et al. Next-generation sequencing strategies during the 2024-2025 avian influenza A(H5N1) emergency response in the U.S. Viruses. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42043271/
Mohammad I, Hajelbashir MI, El-Bidawy MH, et al. Deciphering HPAI influenza A virus (H5N1): Molecular basis of pathogenicity, zoonotic potential, and advances in vaccination strategies. Viruses. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42043199/
European Food Safety Authority (EFSA), European Centre for Disease Prevention and Control (ECDC), European Union Reference Laboratory for Avian Influenza (EURL), et al. Avian influenza overview December 2025-February 2026. EFSA J. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42016297/
Wiggins J, Madapong A, Weaver EA. Dual-route H5N1 vaccination induces systemic and mucosal immunity in murine and bovine models. NPJ Vaccines. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42014782/
Giersch K, Nörz D, Grunwald M, et al. Adaptation and validation of an influenza A subtyping panel for detection of H1pdm09, H3 and H5 on a high-throughput RT-qPCR system. Sci Rep. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42009717/